C4 Therapeutics (CCCC) EBT (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.39% |
| Dec 31, 2025 | 36.69% |
| Sep 30, 2025 | -23.62% |
| Jun 30, 2025 | 1.15% |
| Mar 31, 2025 | 23.58% |
| Dec 31, 2024 | -39.63% |
| Sep 30, 2024 | -39.23% |
| Jun 30, 2024 | 37.53% |
| Mar 31, 2024 | 17.74% |
| Dec 31, 2023 | -32.43% |
| Sep 30, 2023 | 27.53% |
| Jun 30, 2023 | -3.28% |
| Mar 31, 2023 | 6.47% |
| Dec 31, 2022 | -16.36% |
| Sep 30, 2022 | -18.90% |
| Jun 30, 2022 | 15.00% |
| Mar 31, 2022 | -101.94% |
| Dec 31, 2021 | 36.56% |
| Sep 30, 2021 | -9.31% |
| Jun 30, 2021 | -7.67% |
| Mar 31, 2021 | 4.33% |
| Dec 31, 2020 | 0.38% |
| Sep 30, 2020 | -100.73% |
| Jun 30, 2020 | 9.26% |
| Mar 31, 2020 | -19.37% |
| Dec 31, 2019 | -7.15% |